These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8169988)
41. Erythropoietin: biological aspects and clinical usefulness. Liberato NL; Costa A; Barosi G Haematologica; 1990; 75(4):346-62. PubMed ID: 2276680 [TBL] [Abstract][Full Text] [Related]
42. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells. Ganser A; Bergmann M; Völkers B; Grützmacher P; Scigalla P; Hoelzer D Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423 [TBL] [Abstract][Full Text] [Related]
43. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients]. Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783 [TBL] [Abstract][Full Text] [Related]
44. Influence of erythropoietin treatment on 2,3-bisphosphoglycerate and O2-affinity of red blood cells in children with renal anemia. Rapoport I; Engelhardt I; Drung I; Holzhütter H; Schmidt G Biomed Biochim Acta; 1990; 49(2-3):S280-3. PubMed ID: 2386518 [TBL] [Abstract][Full Text] [Related]
45. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report. Salim KA; Salim S; Mathew T J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463 [TBL] [Abstract][Full Text] [Related]
46. Erythropoietin titers in health and disease. Erslev AJ Semin Hematol; 1991 Jul; 28(3 Suppl 3):2-7; discussion 7-8. PubMed ID: 1891720 [No Abstract] [Full Text] [Related]
47. Resistance to recombinant human erythropoietin therapy: a real clinical entity? Stivelman JC Semin Nephrol; 1989 Mar; 9(1 Suppl 2):8-11. PubMed ID: 2669085 [TBL] [Abstract][Full Text] [Related]
48. A mouse model for an erythropoietin-deficiency anemia. Zeigler BM; Vajdos J; Qin W; Loverro L; Niss K Dis Model Mech; 2010; 3(11-12):763-72. PubMed ID: 20959632 [TBL] [Abstract][Full Text] [Related]
50. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients. Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762 [TBL] [Abstract][Full Text] [Related]
51. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747 [TBL] [Abstract][Full Text] [Related]
55. Clinical observation on the treatment of male neoplastic anemia with Yixuesheng capsule combined with recombination human erythropoietin. Cheng Z; Wu JL; Chen JF Chin J Integr Med; 2009 Feb; 15(1):63-5. PubMed ID: 19271173 [TBL] [Abstract][Full Text] [Related]
56. Renoprotective effect of erythropoietin (EPO): possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney. Kang DH; Park EY; Yu ES; Lee YS; Yoon KI Kidney Int; 2005 May; 67(5):1683. PubMed ID: 15840013 [No Abstract] [Full Text] [Related]